Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002735 · ClinicalTrials.gov registry record · Phase 2
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
A Phase 2 study, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- Phase 2
- Development phase
- 68
- Enrollment target
NCT00002735 is a Phase 2 study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 68 participants.
The verdict
NCT00002735, a Phase 2 study, was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 68 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients with stage III or stage IV cancer of the hypopharynx or tongue.
Interventions
- DRUG cisplatin
- DRUG fluorouracil
- RADIATION low-LET cobalt-60 gamma ray therapy
- DRUG Induction chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 1996-04 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002735
The ClinicalTrials.gov registry entry for NCT00002735 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which cisplatin is the first listed.
NCT00002735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002735 about?
NCT00002735 is a clinical study titled "SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase II tria...
What is the current status of trial NCT00002735?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 68 participants. The study started on 1996-04. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00002735?
The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), low-LET cobalt-60 gamma ray therapy (RADIATION), Induction chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00002735?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.